NIM
NVO

Northeast Investment Management’s Novo Nordisk NVO Stock Holding History

Northeast Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,405
Closed -$235K – 185
2025
Q2 		$235K Hold
3,405
– – 0.01% 173
2025
Q1 		$236K Hold
3,405
– – 0.01% 169
2024
Q4 		$293K Sell
3,405
-155
-4% -$16.8K 0.01% 161
2024
Q3 		$424K Hold
3,560
– – 0.02% 143
2024
Q2 		$508K Hold
3,560
– – 0.02% 134
2024
Q1 		$457K Hold
3,560
– – 0.02% 140
2023
Q4 		$368K Buy
3,560
+300
+9% +$29.7K 0.02% 148
2023
Q3 		$296K Hold
3,260
– – 0.02% 159
2023
Q2 		$264K Buy
+3,260
New +$266K 0.01% 164
2022
Q2 		– Sell
-4,060
Closed -$225K – 197
2022
Q1 		$225K Hold
4,060
– – 0.01% 195
2021
Q4 		$227K Buy
+4,060
New +$220K 0.01% 195
2016
Q4 		– Sell
-80,214
Closed -$1.67M – 162
2016
Q3 		$1.67M Sell
80,214
-12,606
-14% -$313K 0.17% 83
2016
Q2 		$2.5M Sell
92,820
-69,824
-43% -$1.91M 0.25% 71
2016
Q1 		$4.41M Sell
162,644
-6,298
-4% -$169K 0.45% 60
2015
Q4 		$4.91M Buy
168,942
+2,382
+1% +$65.9K 0.51% 56
2015
Q3 		$4.52M Buy
166,560
+2,656
+2% +$75.2K 0.49% 60
2015
Q2 		$4.49M Sell
163,904
-2,040
-1% -$57.3K 0.45% 61
2015
Q1 		$4.43M Sell
165,944
-10,818
-6% -$249K 0.43% 60
2014
Q4 		$3.74M Sell
176,762
-10,836
-6% -$242K 0.37% 64
2014
Q3 		$4.47M Sell
187,598
-5,292
-3% -$122K 0.45% 61
2014
Q2 		$4.46M Buy
192,890
+11,252
+6% +$248K 0.45% 60
2014
Q1 		$4.15M Buy
181,638
+57,038
+46% +$1.22M 0.44% 63
2013
Q4 		$2.3M Buy
124,600
+64,330
+107% +$1.12M 0.26% 74
2013
Q3 		$1.02M Buy
+60,270
New +$1.01M 0.12% 95

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northeast Investment Management's NVO Position: Q3 2025 in Review

Northeast Investment Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,405 shares — an estimated $235K sold.

Northeast Investment Management first reported a position in NVO in Q3 2013 and held it in 24 quarters. The position peaked at $4.91M in Q4 2015. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Northeast Investment Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Northeast Investment Management sold 3,405 Novo Nordisk shares in Q3 2025, an estimated $235K.
  • Northeast Investment Management first reported a position in Novo Nordisk in Q3 2013 and held it in 24 quarters.
  • Northeast Investment Management's Novo Nordisk position peaked at $4.91M in Q4 2015.
  • 1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Northeast Investment Management's 13F filing for Q3 2025, filed 7 Nov 2025.